IPHA
Innate Pharma
IPHA
IPHA
5 hedge funds and large institutions have $296K invested in Innate Pharma in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
Optiver Holding
Amsterdam,
Netherlands
|
$15K |
| 3 |
Morgan Stanley
New York
|
$121K |
| 4 |
LPL Financial
San Diego,
California
|
$0 |
| 5 |
Millennium Management
New York
|
$155K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $155K | -$9.83K | -2,967 | -6% |
|
|
2
Morgan Stanley
New York
| $121K | -$64.3K | -19,480 | -35% |
|
|
3
Optiver Holding
Amsterdam,
Netherlands
| $15K | -$86.1K | -25,791 | -85% |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $3K | -$3K | -1,000 | -50% |
|
|
SPIA
5
Steward Partners Investment Advisory
New York
| $2K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$109K | -25,250 | Closed |
|
|
7
LPL Financial
San Diego,
California
| – | -$52K | -12,000 | Closed |
|